HCPCS Code Descriptor:
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
00069-0291-01, 00069-0291-10, 00069-0292-01, 00069-0292-10, 00069-0293-10, 00069-0294-10
Oncology Biosimilar Colony Stimulating Factor
Route of Administration:
NIVESTYM is an Oncology Biosimilar Colony Stimulating Factor drug manufactured by Pfizer and administered via the Injection route of administration. The Q Code: Q5110 is aligned to the drug NIVESTYM.
Nivestym (pegfilgrastim) is an artificial protein that aids the production of white blood cells (neutrophils). Nivestym is manufactured by Pfizer and is biosimilar to the drug Neupogen (J1442). This drug has one HCPCS code, Q5110 that has been aligned to the medication since October 2018. Patient assistance programs for this medication can be found through Pfizer RxPathways.